Your browser doesn't support javascript.
loading
The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease.
Beca, Francisco; Oh, Hannah; Collins, Laura C; Tamimi, Rulla M; Schnitt, Stuart J.
Affiliation
  • Beca F; Department of Pathology, Stanford University Medical School, Stanford, CA, USA.
  • Oh H; Interdisciplinary Program in Precision Public Health, College of Health Sciences, Korea University, Seoul, South Korea.
  • Collins LC; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • Tamimi RM; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Schnitt SJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. sschnitt@bwh.harvard.edu.
NPJ Breast Cancer ; 7(1): 23, 2021 Mar 05.
Article in En | MEDLINE | ID: mdl-33674619
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Language: En Journal: NPJ Breast Cancer Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Language: En Journal: NPJ Breast Cancer Year: 2021 Type: Article Affiliation country: United States